The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $10.48 in the last session, down -3.14% from day before closing price of $10.82. In other words, the price has decreased by -$3.14 from its previous closing price. On the day, 1.27 million shares were traded. ORIC stock price reached its highest trading level at $10.89 during the session, while it also had its lowest trading level at $10.4.
Ratios:
We take a closer look at ORIC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.13 and its Current Ratio is at 16.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $15. On October 31, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $20.Wells Fargo initiated its Overweight rating on October 31, 2024, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 22 ’25 when Jacob Chacko bought 250,000 shares for $10.50 per share.
Piscitelli Dominic sold 20,000 shares of ORIC for $200,972 on Jul 01 ’25. The Chief Financial Officer now owns 48,317 shares after completing the transaction at $10.05 per share. On Jun 24 ’25, another insider, Piscitelli Dominic, who serves as the Chief Financial Officer of the company, sold 32,466 shares for $10.50 each. As a result, the insider received 341,039 and left with 68,317 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 1050870656 and an Enterprise Value of 743420928.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.65, which has changed by 0.047999978 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.67, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is 0.62%, while the 200-Day Moving Average is calculated to be 21.74%.
Shares Statistics:
According to the various share statistics, ORIC traded on average about 1.12M shares per day over the past 3-months and 1636360 shares per day over the past 10 days. A total of 86.19M shares are outstanding, with a floating share count of 55.87M. Insiders hold about 42.47% of the company’s shares, while institutions hold 63.04% stake in the company. Shares short for ORIC as of 1756425600 were 8174386 with a Short Ratio of 7.31, compared to 1753920000 on 6758787. Therefore, it implies a Short% of Shares Outstanding of 8174386 and a Short% of Float of 8.520000399999999.
Earnings Estimates
Its stock is currently analyzed by 11.0 different market analysts. The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.29 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.29 and -$2.53 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.71, with 11.0 analysts recommending between -$1.03 and -$2.84.
